Progyny, Inc. revenue by segment PGNY

Progyny, Inc. splits its revenue into 2 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Fertility Benefit Services at $830.9 million, 64% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2026
Sep 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
Revenue
1,339
1,289
1,167
1,089
787
501
345
230
Fertility Benefit Services
872
+7.6%
share 65.1%
831
+13.9%
share 64.5%
730
+7.9%
share 62.5%
676
+32.6%
share 62.1%
510
+43.5%
share 64.8%
356
+40.3%
share 71.0%
254
+33.7%
share 73.5%
190
share 82.6%
Pharmacy Benefit Services
467
+1.8%
share 34.9%
458
+4.6%
share 35.5%
438
+6.2%
share 37.5%
412
+49.0%
share 37.9%
277
+90.9%
share 35.2%
145
+58.8%
share 29.0%
91
+127.9%
share 26.5%
40
share 17.4%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
PGNY (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Large accelerated filer
SEC CIK
1551306
Former names
Auxogyn, Inc. (until Mar 19, 2015); Auxogyn Inc (until Sep 16, 2013)

Other Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.